VivoSim Labs, Inc. Debt Issuance Costs, Gross
VivoSim Labs, Inc. (VIVS) had Debt Issuance Costs, Gross of $0 as of 2013-03-31, per its 10-KT filed 2013-05-24.
Discontinued › Notes › Debt
us-gaap:DeferredFinanceCostsGross · last filed 2013-05-24
- 2013-03-31: Debt Issuance Costs, Gross $0.00.
- 2012-12-31: Debt Issuance Costs, Gross $0.00.
- 2012-09-30: Debt Issuance Costs, Gross $0.00.
- 2012-06-30: Debt Issuance Costs, Gross $0.00.
| Period end | Debt Issuance Costs, Gross |
|---|---|
| 2013-03-31 | $0.00 10-KT · filed 2013-05-24 |
| 2012-12-31 | $0.00 10-KT · filed 2013-05-24 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-14 |
| 2011-12-31 | $140.00K 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |